Consolidated Financial Statement Detail (Tables)

12 Months Ended

Dec. 31, 2013

Consolidated Financial Statement Detail [Abstract]

Receivables

Receivables consisted of the following at December 31, 2013 and 2012 (in thousands):

	December 31,
	2013		2012
Trade receivables, net	$	3,731	$	7,477
Other receivables		50		772
Total	$	3,781	$	8,249

Property and equipment

Property and equipment consisted of the following at December 31, 2013 and 2012 (in thousands):

	December 31,
	2013			2012
Equipment and furniture	$	28,365		$	25,734
Buildings, leasehold and building improvements		9,316			21,656
Construction-in-progress		225			1,832
Land		310			310
		38,216			49,532
Less:  Accumulated depreciation and amortization		(31,760	)		(41,389	)
Property and equipment, net	$	6,456		$	8,143

Accrued liabilities

Accrued liabilities consisted of the following at December 31, 2013 and 2012 (in thousands):

	December 31,
	2013		2012
Accrued management incentive compensation	$	4,386	$	3,978
Accrued payroll and other benefits		3,009		2,461
Accrued clinical trial costs		878		4,702
Other		1,661		1,904
Total	$	9,934	$	13,045